STEX vs NMTC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMTC Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeuroOne Medical Technologies Corporation Common Stock (NMTC) driven by superior Growth & Margin, Momentum & Technical while STEX counters with relative strength in Options & Structure. Fundamentally, STEX trades at N/M Forward P/E with -36966.7% operating margin (+0.0% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, STEX sits in UNCLASSIFIED (61st %ile IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | STEX Revenue | NMTC Revenue | STEX Op. Margin | NMTC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2012 | N/A | $0M | N/A | -1491.1% | NMTC |
| FY2013 | N/A | $0M | N/A | -2009.0% | NMTC |
| FY2014 | N/A | $0M | N/A | -4646.1% | NMTC |
| FY2021 | $0M | $0M | -7576.2% | -5735.9% | NMTC |
| FY2022 | $0M | $0M | -9533.2% | -5860.2% | NMTC |
| FY2023 | $0M | $0M | -158400.0% | -612.3% | NMTC |
| FY2024 | $0M | $0M | -32155.0% | -344.3% | NMTC |
| FY2025 | N/A | $10M | N/A | -46.5% | NMTC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | STEX | NMTC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $56.2M | $6.1M | Larger Scale | STEX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +16.3% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | -36966.7% | -63.4% | Higher Margin | NMTC |
| Net Profit Margin Profitability | 0.0% | -59.7% | Higher Margin | STEX |
| Return on Equity (ROE) Capital Efficiency | -775.2% | -124.7% | Higher ROE | NMTC |
| 52-Week Range Position Momentum | 2% ($0โ$5) | 2% ($1โ$5) | Stronger Trend | NMTC |
| Beta / 30D Volatility Risk Regime | 1.71ฮฒ ยท 127% Vol | 1.55ฮฒ ยท 105% Vol | Lower Realized Risk | NMTC |
| Unified Institutional Score Composite Signal | 51.3 / 100 (HOLD) | 45.5 / 100 (HOLD) | Higher Composite | STEX |